Defense bill’s China, biotech research provisions likely to have limited impact

The National Defense Authorization Act, which is expected to pass before year-end, includes provisions intended to reshape the federal government’s approach to biotechnology by restricting relationships with Chinese firms deemed to pose national security risks and accelerating the commercialization of DoD-funded biotech research.

Its impacts would likely be limited on both fronts, should it become law in this form. ...